Literature DB >> 9810508

Distribution of central catecholaminergic neurons: a comparison between ungulates, humans and other species.

Y Tillet1, K Kitahama.   

Abstract

In ungulates and primates, the distribution of central catecholaminergic neurons identified using antibodies raised against catecholamine synthesizing enzymes and catecholamines themselves, shows many differences if compared to rats. Catecholaminergic neurons are more loosely clustered in ungulates and primates than in rat. In the medulla oblongata, the density of noradrenergic/adrenergic neurons is lower in ungulates than in other species and, particularly in sheep, the adrenergic group C1 is not observed. The noradrenergic neurons of the locus coeruleus are present in a larger area in ungulates than in rodents. In the hypothalamus, the density of dopamine neurons is lower in ungulates and primates than in rodents. In the rostral hypothalamus of ungulates, the dorsal part of the group A14 is missing, and these species present only the ventral part of the group A15. In primates the group A15 extends into the supraoptic and paraventricular nuclei which have large tyrosine hydroxylase-immunoreactive (TH-IR) neurons not observed in other species. In addition, in all studies species, not all cells expressing catecholamine synthesizing enzymes also express catecholamines, as found in some TH-IR neurons in the arcuate nucleus, thereby demonstrating the necessity of using different markers to ascertain the true catecholaminergic nature of labeled neurons. These anatomical differences between species show the difficulty in extrapolating the distribution of catecholamine neurons from one species to another and may be related to adaptative physiological differences between mammals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9810508     DOI: 10.14670/HH-13.1163

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  4 in total

1.  Estrogen inhibits tuberoinfundibular dopaminergic neurons but does not cause irreversible damage.

Authors:  Gustavo R Morel; Rubén W Carón; Gloria M Cónsole; Marta Soaje; Yolanda E Sosa; Silvia S Rodríguez; Graciela A Jahn; Rodolfo G Goya
Journal:  Brain Res Bull       Date:  2009-09-08       Impact factor: 4.077

2.  Glial cell line-derived neurotrophic factor gene therapy ameliorates chronic hyperprolactinemia in senile rats.

Authors:  G R Morel; Y E Sosa; M J Bellini; N G Carri; S S Rodriguez; M C Bohn; R G Goya
Journal:  Neuroscience       Date:  2010-02-26       Impact factor: 3.590

3.  Neurokinin B acts via the neurokinin-3 receptor in the retrochiasmatic area to stimulate luteinizing hormone secretion in sheep.

Authors:  Heather J Billings; John M Connors; Stephanie N Altman; Stanley M Hileman; Ida Holaskova; Michael N Lehman; Christina J McManus; Casey C Nestor; Britni H Jacobs; Robert L Goodman
Journal:  Endocrinology       Date:  2010-06-02       Impact factor: 4.736

Review 4.  Stress and the dopaminergic reward system.

Authors:  Ja-Hyun Baik
Journal:  Exp Mol Med       Date:  2020-12-01       Impact factor: 8.718

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.